Hormone linked to immune suppression may improve cancer immunotherapy
TL;DR Summary
Researchers at UT Southwestern discovered that a hormone called SCG2 interacts with the receptor LILRB4 on immune cells, suppressing their ability to fight cancer. Blocking this interaction in mice slowed tumor growth, suggesting a new potential target for cancer immunotherapy, while enhancing it could help treat inflammatory disorders.
- A hormone that silences the immune system may unlock new cancer treatments ScienceDaily
- New data sheds light on immunotherapy failure, bringing hope to patients with cancer Medical Xpress
- Research identifies a culprit behind cancer immunotherapy failures Laboratory News
- Protein in blood linked to immunotherapy resistance Labmate Online
- New study shows how cancer tricks the immune system with the help of a hormone Earth.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
92%
617 → 48 words
Want the full story? Read the original article
Read on ScienceDaily